Table 1.
GnRHa Cohort (N=95) | |||||
---|---|---|---|---|---|
Total Sample | Designated Female at Birth | Designated Male at Birth | t or χ2 (df) | p-value | |
Total n (%) | 95 | 46 (48.4) | 49 (51.6) | ||
Age M (SD) | 11.22 (1.46) | 10.76 (1.43) | 11.65 (1.36) | 3.11 (93) | .002 |
Gender Identity | |||||
Transmasculine/Male | 41 (43.2) | 40 (87) | 1 (2) + | 78.28 (2) | 0.000 |
Transfeminine/Female | 45 (47.4) | 1 (2.2) + | 44 (89.8) | ||
Non-binary | 9 (9.5) | 5 (10.9) | 4 (8.2) | ||
Race/Ethnicity | |||||
White | 50 (52.6) | 31 (67.4) | 19 (38.8) | 10.01 (5) | .075 |
Latinx | 21 (22.1) | 8 (17.4) | 13 (26.5) | ||
Black/African-American | 3 (3.2) | 1 (2.2) | 2 (4.1) | ||
Multiracial | 13 (13.7) | 5 (10.9) | 8 (16.3) | ||
Other | 4 (4.2) | - | 4 (8.2) | ||
Unreported | 4 (4.2) | 102 | 3 (6.1) | ||
GAH Cohort (N=316) | |||||
Total Sample | Designated Female at Birth | Designated Male at Birth | t or χ2 (df) | p-value | |
Total n (%) | 316 | 205 (64.9) | 111 (35.1) | ||
Age M (SD) | 16 (1.88) | 15.87 (1.76) | 16.23 (2.08) | 1.57 (195.29) | 0.12 |
Gender Identity | |||||
Transmasculine | 191 (60.4) | 191 (93.72) | - | 293.64 (2) | 0.000 |
Transfeminine/Female | 106 (33.5) | 1 (0.5) + | 105 (94.6) | ||
Non-binary | 19 (6.0) | 13 (6.3) | 6 (5.4) | ||
Race/Ethnicity | |||||
White | 196 (62.0) | 127 (62.0) | 69 (62.2) | 2.17 (4) | 0.71 |
Latinx | 70 (22.2) | 49 (23.9) | 21 (18.9) | ||
Black/African-American | 14 (4.4) | 10 (4.9) | 4 (3.6) | ||
Multiracial | 10 (3.2) | 5 (2.4) | 5 (4.5) | ||
Other | 23 (7.3) | 14 (6.8) | 9 (8.1) | ||
Unknown/unreported | 3 (0.9) | - | 3 (2.7) |
Note. GnRHa = gonadotropin releasing hormone agonists. GAH = gender-affirming hormones. M = mean; SD = standard deviation
Participant’s designated sex at birth was concordant with their reported gender identity at the point of baseline.